التفاصيل البيبلوغرافية
| العنوان: |
Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy. |
| المؤلفون: |
Ruszkowska, Barbara, Sokup, Alina, Kulwas, Arleta, Kwapisz, Justyna, Góralczyk, Krzysztof, Socha, Maciej W., Rhone, Piotr, Rość, Danuta |
| المصدر: |
Acta Obstetricia et Gynecologica Scandinavica; Jul2013, Vol. 92 Issue 7, p841-846, 6p |
| مصطلحات موضوعية: |
ADIPONECTIN, ENDOTHELIAL cells, BIOMARKERS, POSTMENOPAUSE, TRANSDERMAL medication, HORMONE therapy, PLASMINOGEN |
| مستخلص: |
Objective To assess the concentration of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen in postmenopausal women who received oral or transdermal hormone therapy. Design Case-control study. Setting Polish university hospitals. Population Seventy-six healthy postmenopausal women. Method Forty-six women who received oral ( n = 26) or transdermal ( n = 20) hormone therapy and a control group without such medication ( n = 30), all aged 44-58 years. Main outcome measures Plasma concentrations of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen by enzyme-linked immunosorbent assay. Results We found a significantly higher concentration of adiponectin in women on oral and transdermal therapy in comparison to the control group and a significantly lower concentration of soluble E-selectin in women who received oral hormone therapy vs. the control group. A significantly higher concentration of tissue activator plasminogen antigen was obtained in the group of women using transdermal menopausal hormone therapy compared with those receiving oral therapy and with the control group. Conclusions Reduced levels of soluble E-selectin in women using menopausal hormone therapy could lead to reduction in the intensity of expression of the adhesion factors on the surface of the vascular endothelium. Menopausal hormone therapy might have advantageous effects on vascular endothelial function through adiponectin. Transdermal therapy may have adverse effects associated with elevated tissue activator plasminogen antigen levels and thereby the higher risk of ischemic heart disease. [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Obstetricia et Gynecologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder